ICD-10-CM Codes
C00-D49
D3A-D3A
D3A-
2023 ICD-10-CM Diagnosis Code D3A

2023 ICD-10-CM Diagnosis Code D3A

Benign neuroendocrine tumors

2016

2017

2018

2019

2020

2021

2022

2023

Non-Billable/Non-Specific Code

D3A should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2023 edition of ICD-10-CM D3A became effective on October 1, 2022.
This is the American ICD-10-CM version of D3A - other international versions of ICD-10 D3A may differ.

Use Additional

Use Additional Help

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.

code to identify any associated endocrine syndrome, such as:
carcinoid syndrome (
ICD-10-CM Diagnosis Code E34.0
Carcinoid syndrome
Note
- May be used as an additional code to identify functional activity associated with a carcinoid tumor.
E34.0
)

Code Also

Code Also Help

A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.

any associated multiple endocrine neoplasia [MEN] syndromes (
ICD-10-CM Diagnosis Code E31.2
Multiple endocrine neoplasia [MEN] syndromes
Applicable To
- Multiple endocrine adenomatosis
Code Also
- any associated malignancies and other conditions associated with the syndromes
E31.2-
)

Type 2 Excludes

Type 2 Excludes Help

A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D3A) and the excluded code together.

benign pancreatic islet cell tumors (
ICD-10-CM Diagnosis Code D13.7
Benign neoplasm of endocrine pancreas
Applicable To
- Islet cell tumor
- Benign neoplasm of islets of Langerhans
Use Additional
- code to identify any functional activity.
D13.7
)

The following code(s) above D3A contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D3A:

C00-D49
2023 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms

Clinical Information

A benign neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells.
A paraganglioma that is confined to the site of origin, without metastatic potential.

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change

ICD-10-CM Codes Adjacent To D3A

D36.10 …… unspecified

D36.11 …… of face, head, and neck

D36.12 …… upper limb, including shoulder

D36.13 …… of lower limb, including hip

D36.14 …… of thorax

D36.15 …… of abdomen

D36.16 …… of pelvis

D36.17 …… of trunk, unspecified

D36.7 Benign neoplasm of other specified sites

D36.9 Benign neoplasm, unspecified site

D3A Benign neuroendocrine tumors

D3A.0 Benign carcinoid tumors

D3A.00 Benign carcinoid tumor of unspecified site

D3A.01 Benign carcinoid tumors of the small intestine

D3A.010 Benign carcinoid tumor of the duodenum

D3A.011 Benign carcinoid tumor of the jejunum

D3A.012 Benign carcinoid tumor of the ileum

D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion

D3A.02 Benign carcinoid tumors of the appendix, large intestine, and rectum

D3A.020 Benign carcinoid tumor of the appendix

D3A.021 Benign carcinoid tumor of the cecum

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2023 ICD-10-CM Diagnosis Code D3A

Benign neuroendocrine tumors

Carcinoid syndrome

Multiple endocrine neoplasia [MEN] syndromes

Benign neoplasm of endocrine pancreas

Neoplasms